TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...

Profound Medical (NASDAQ:PROF) soared on Monday as investment bank Raymond James raised its rating on the medical device company to Strong Buy from Outperform and maintained a price target of $20.00.

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...

Profound Medical (NASDAQ:PROF) is set to give its latest quarterly earnings report on Thursday, 2026-03-05. Here's what investors need to know before the announcement. Analysts estimate that Profound ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound” or the "Company”), a commercial-stage medical device company that develops and markets innovative ...

The latest price target for Profound Medical (NASDAQ:PROF) was reported by Lake Street on April 23, 2025. The analyst firm set a price target for $11.00 expecting PROF to rise to within 12 months (a ...

The medical technology sector, worth hundreds of billions of dollars, has experienced steady growth for years. And while it remains strong, recent headwinds are creating a more challenging environment ...

Q4-2025 revenue grew 43% year-over-year and 13% sequentially quarter-over-quarter to a record $6.0 million. 67% were treated for prostate cancer only, 17% were hybrid patients suffering from both ...